Bavarian Nordic - The sky is the limit
eröffnet am 04.06.11 19:10:57 von
neuester Beitrag 11.05.24 15:19:17 von
neuester Beitrag 11.05.24 15:19:17 von
Beiträge: 2.177
ID: 1.166.681
ID: 1.166.681
Aufrufe heute: 10
Gesamt: 103.230
Gesamt: 103.230
Aktive User: 0
ISIN: DK0015998017 · WKN: 917165 · Symbol: BV3
21,845
EUR
-0,30 %
-0,065 EUR
Letzter Kurs 10.05.24 L&S Exchange
Neuigkeiten
08.05.24 · globenewswire  |
08.05.24 · globenewswire |
07.05.24 · globenewswire |
29.04.24 · globenewswire |
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 8,8800 | +57,45 | |
| 17,440 | +44,61 | |
| 1,9750 | +27,42 | |
| 1,8400 | +26,03 | |
| 4,9500 | +25,32 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 10,965 | -18,48 | |
| 0,7845 | -19,36 | |
| 3,3200 | -22,61 | |
| 0,6785 | -26,19 | |
| 3,3100 | -77,44 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 75.765.237 von Beutelschneider2020 am 10.05.24 17:40:49
Bavarian Nordic verdient Geld und kauft auf niedrigem Niveau weiter eigene Aktien zurück.
Bavarian Nordic kauft weiter eigene Aktien zurück
https://www.wallstreet-online.de/nachricht/18071400-bavarian…Bavarian Nordic verdient Geld und kauft auf niedrigem Niveau weiter eigene Aktien zurück.
Antwort auf Beitrag Nr.: 75.698.442 von Flymetothemoon am 28.04.24 20:29:50
So langsam könnte man wirklich mal wieder ein bischen investieren. Beim Ausbruch 2022 liess sich hier schnell eine Menge Geld verdienen.
Geht es etwa wieder los?
Zitat von Flymetothemoon: https://www.kasu.org/health-science/2024-04-26/drc-is-seeing-its-worst-mpox-outbreak-but-has-no-vaccines-or-treatments-yet-why
So langsam könnte man wirklich mal wieder ein bischen investieren. Beim Ausbruch 2022 liess sich hier schnell eine Menge Geld verdienen.
BAVARIAN NORDIC RECEIVES 65M EUR CONTRACT TO SUPPLY SMALLPOX VACCINES FOR EU STRATEGIC RESERVE
April 29, 2024
Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued at EUR 65 million to supply its MVA-BN® smallpox vaccine to the strategic reserve within the European Union (EU) in 2025. This third, and larger order follows two previous orders, received in 2023 and delivered in 2024, for smallpox vaccines to rescEU stockpiles across Europe and will help to expand the EU’s capability to respond to future biological threats and emergencies by enabling rapid deployment of medical countermeasures to its member states.
https://www.bavarian-nordic.com/media/media/news.aspx?news=6…
April 29, 2024
Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued at EUR 65 million to supply its MVA-BN® smallpox vaccine to the strategic reserve within the European Union (EU) in 2025. This third, and larger order follows two previous orders, received in 2023 and delivered in 2024, for smallpox vaccines to rescEU stockpiles across Europe and will help to expand the EU’s capability to respond to future biological threats and emergencies by enabling rapid deployment of medical countermeasures to its member states.
https://www.bavarian-nordic.com/media/media/news.aspx?news=6…
Antwort auf Beitrag Nr.: 75.702.255 von Nokery am 29.04.24 15:42:27The CHIKV VLP vaccine candidate received Breakthrough Therapy designation and Fast Track designation from the FDA in October 2020 and April 2018, respectively, and PRIME designation from the EMA in September 2019. These designations are designed to facilitate the development or expedite review of medicines that either target an unmet medical need or may demonstrate substantial improvement over available therapy. In February 2024, the Committee for Medicinal Products for Human Use (CHMP) under EMA granted accelerated assessment for the MAA for the CHIKV VLP vaccine candidate, which Bavarian Nordic plans to submit by mid-2024.
BAVARIAN NORDIC INITIATES ROLLING SUBMISSION OF BIOLOGICS LICENSE APPLICATION WITH FDA FOR ITS CHIKUNGUNYA VACCINE CANDIDATE
COPENHAGEN, Denmark, April 29, 2024
– Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a Biologics License Application (BLA) for the licensure of its CHIKV VLP vaccine candidate for immunization against chikungunya virus infection in individuals 12 years of age and older.
Bavarian Nordic will submit additional data over the coming months, aiming to complete the BLA submission before the end of the first half of 2024 to support a potential FDA approval of the vaccine in the first half of 2025.
https://www.bavarian-nordic.com/media/media/news.aspx?news=6…
COPENHAGEN, Denmark, April 29, 2024
– Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a Biologics License Application (BLA) for the licensure of its CHIKV VLP vaccine candidate for immunization against chikungunya virus infection in individuals 12 years of age and older.
Bavarian Nordic will submit additional data over the coming months, aiming to complete the BLA submission before the end of the first half of 2024 to support a potential FDA approval of the vaccine in the first half of 2025.
https://www.bavarian-nordic.com/media/media/news.aspx?news=6…
Trading Spotlight
DRC is seeing its worst mpox outbreak — but has no vaccines or treatments yet.
https://www.kasu.org/health-science/2024-04-26/drc-is-seeing… Affenpocken-Virus mutiert, Hunderte infiziert: Forscher befürchten neue Pandemie.
Ein neuer Affenpocken-Stamm mit "Pandemie-Potenzial" wurde in einer Bergbaustadt im Kongo entdeckt. Forschungsergebnisse lassen das Schlimmste befürchten - darum ist die neuartige Mutation "Clade 1b" so gefährlich.https://www.tag24.de/thema/affenpocken/pandemie-potenzial-ne…
Affenpocken-Virus mutiert, Hunderte infiziert: Forscher befürchten neue Pandemie.
Ein neuer Affenpocken-Stamm mit "Pandemie-Potenzial" wurde in einer Bergbaustadt im Kongo entdeckt. Forschungsergebnisse lassen das Schlimmste befürchten - darum ist die neuartige Mutation "Clade 1b" so gefährlich.
https://www.tag24.de/thema/affenpocken/pandemie-potenzial-ne…
Ein neuer Affenpocken-Stamm mit "Pandemie-Potenzial" wurde in einer Bergbaustadt im Kongo entdeckt. Forschungsergebnisse lassen das Schlimmste befürchten - darum ist die neuartige Mutation "Clade 1b" so gefährlich.
https://www.tag24.de/thema/affenpocken/pandemie-potenzial-ne…
Mutated strain of mpox with ‘pandemic potential’ found in DRC mining town
Researchers call for ‘swift action’ to halt the outbreak in Democratic Republic of Congo as experts warn virus is ‘not over’
https://www.telegraph.co.uk/global-health/science-and-diseas…
Researchers call for ‘swift action’ to halt the outbreak in Democratic Republic of Congo as experts warn virus is ‘not over’
https://www.telegraph.co.uk/global-health/science-and-diseas…
BAVARIAN NORDIC’S CHIKUNGUNYA VACCINE CANDIDATE GRANTED ACCELERATED ASSESSMENT BY EUROPEAN MEDICINES AGENCY
Accelerated assessment allows for a shorter review period with EMA.
Bavarian Nordic is on track to submit its Marketing Authorisation Application for CHIKV VLP to EMA during H1 2024.
https://www.bavarian-nordic.com/investor/news/news.aspx?news…
Accelerated assessment allows for a shorter review period with EMA.
Bavarian Nordic is on track to submit its Marketing Authorisation Application for CHIKV VLP to EMA during H1 2024.
https://www.bavarian-nordic.com/investor/news/news.aspx?news…
Durchsuchen
